Market Place
Sourcing Support
Lipidor updates on Phase III study of AKP02 in psoriasis
19 May 2022 //
PRNEWSWIRE
Lipidor expands clinical program, invests in new project against acne vulgaris
16 Dec 2021 //
PRNEWSWIRE
Lipidor submits new patent application; collaborates with Cannassure
29 Oct 2021 //
PRNEWSWIRE
Lipidor announces approval to start PhIII clinical study of AKP02
27 Sep 2021 //
PRNEWSWIRE
Lipidor AB licence agreement grants Menarini Group company
01 Jul 2021 //
PR NEWSWIRE
Lipidor update on the company`s ph III clinical trial of drug candidate AKP02
22 Apr 2021 //
PRNEWSWIRE
Lipidor and Cannassure enter exclusive licensing agreement regarding topical
18 Jan 2021 //
PRNEWSWIRE
Lipidor signs cooperation agreement with contract manufacturer
16 Dec 2020 //
PRNEWSWIRE
Lipidor Signs Agreement With CRO for Implementation Ph III Study Drug AKP-02
08 Jul 2020 //
PRNEWSWIRE
Lipidor Signs Agreement With CRO for Implementation Ph III Clinical Study AKP-02
08 Jul 2020 //
PRNEWSWIRE
Lipidor AB (publ) Formalizes Relationship With Subsidiary Emollivet AB
30 Jun 2020 //
PRNEWSWIRE
Lipidor Presents Updated Project Plan - Initiates Ph III study of AKP02 in-House
07 May 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.